Replies to post #5660 on GTC Biotherapeutics (fka GTCB)

[vinmantoo]

<<Even at the price premium to plasma-derived AT, the sales for HD will be relatively small and Leo gets most of the profit.>>

You need to add "in Europe". We need to see what kind of a deal GTCB can make for profits in the US market.

[kris_kade]

Dew, Thanks for the clarification. All the more this validates and now infact makes it interesting for the partnership deal here at US for HD indication alone, where GTCB should have much better share in the profits.